Stevanato Group S.p.A. Ordinary Shares (STVN) Covered Calls
Stevanato Group S.p.A. is a leading global provider of drug containment, drug delivery, and diagnostic solutions for the pharmaceutical and life sciences industries. The company specializes in high-precision glass and plastic systems, including pre-fillable syringes, vials, and cartridges, alongside integrated engineering solutions for pharmaceutical manufacturing. Based in Italy, it serves as a critical partner for the delivery of biologics, vaccines, and GLP-1 therapies.
You can sell covered calls on Stevanato Group S.p.A. Ordinary Shares to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for STVN (prices last updated Mon 4:16 PM ET):
| Stevanato Group S.p.A. Ordinary Shares (STVN) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 13.81 | +0.29 | 13.15 | 14.37 | 1.8M | 23 | 0.0 |
| Covered Calls For Stevanato Group S.p.A. Ordinary Shares (STVN) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| Apr 17 | 15 | 0.00 | 14.37 | 0.0% | 0.0% | |
| May 15 | 15 | 0.00 | 14.37 | 0.0% | 0.0% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Stevanato Group S.p.A. (STVN) is a mission-critical supplier to the global healthcare industry, operating through two primary segments: Biopharmaceutical and Diagnostic Solutions (BDS) and Engineering. The company is a global leader in "ready-to-use" (RTU) drug containment, providing the primary packaging for a significant portion of the world’s injectable drugs. Its Engineering segment complements this by designing the high-speed assembly and inspection machinery used on pharmaceutical production lines.
The company is currently benefiting from the massive expansion of the GLP-1 (diabetes and weight loss) market, which requires high volumes of high-precision syringes and pen injectors. By focusing on High-Value Solutions (HVS), Stevanato has moved up the value chain, offering specialized coatings and complex delivery devices that command higher margins than standard glass vials. To support this growth, the firm is aggressively expanding capacity at its new facility in Fishers, Indiana, to provide domestic supply to the North American market.
Competitive Landscape
- West Pharmaceutical Services: The primary peer in the injectable drug administration space.
- Becton, Dickinson and Co. (BD): The global leader in pre-filled syringes and a major rival for large pharma contracts.
- Solventum (SOLV): A diversified competitor in healthcare supplies and medical technology.
- Thermo Fisher Scientific (TMO): Competes in the broader bioprocessing and diagnostic infrastructure sectors.
- Danaher Corporation: A key provider of advanced tools for drug development and manufacturing.
Strategic Outlook and Innovation
For 2026, Stevanato is focusing on its "Value Chain Ascent" strategy, transitioning from a glass manufacturer to a full-service drug delivery partner. The company has integrated AI into its inspection equipment to ensure zero-defect production and is developing wearable, large-volume delivery systems for at-home administration of complex biologics. With strategic partnerships in place with major GLP-1 producers, the firm is positioned for long-term growth as the pharmaceutical industry shifts toward more sophisticated, patient-centric delivery formats.
| Top 10 Open Interest For Apr 17 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | NVDA covered calls | 6. | KWEB covered calls | 1. | TVTX covered calls | |
| 2. | SLV covered calls | 7. | TSLA covered calls | 2. | CMPX covered calls | |
| 3. | EEM covered calls | 8. | TLT covered calls | 3. | CAR covered calls | |
| 4. | QQQ covered calls | 9. | HYG covered calls | 4. | VISN covered calls | |
| 5. | SPY covered calls | 10. | SOFI covered calls | 5. | AXTI covered calls | |
Want more examples? STUB Covered Calls | STWD Covered Calls
Risk Disclosure: Trading options involves significant risk and is not suitable for all investors. The information provided on this website is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. Nothing contained on this site is an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities or financial instruments.
Covered Call Strategy Risks: While covered call writing is often considered a conservative options strategy, it is not without risk. By selling a covered call, you are limiting your potential upside profit from the underlying stock. You remain exposed to the full downside risk of owning the underlying stock. In the event of a significant decline in the stock price, the premium received may not be sufficient to offset your losses.
No Guarantee of Performance: Past performance is not indicative of future results. Any examples, calculations, or hypothetical scenarios presented on this site are for illustrative purposes only and do not guarantee future returns or outcomes. Market conditions, liquidity, and trading system failures can affect your ability to execute trades at desired prices.
You should consult with a qualified professional advisor and conduct your own due diligence before making any investment decisions. By using this website, you acknowledge that you are responsible for your own investment decisions and agree to release this site and its affiliates from any liability relating to your use of this information. See the OCC's Characteristics and Risks of Standardized Options for more info.
